Literature DB >> 6205601

Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms.

R V Lloyd, T Mervak, K Schmidt, T F Warner, B S Wilson.   

Abstract

Twenty pancreatic endocrine tumors and one duodenal somatostatinoma were stained with polyclonal antisera against eight hormones, neuron-specific (NSE), and with a monoclonal antibody against the endocrine granule protein chromogranin. Silver staining was performed on all tumors with the Grimelius method. All the tumors and all cells in the normal pancreatic islet showed NSE immunoreactivity. Chromogranin immunoreactivity was found predominantly in the glucagon cells of normal islets, in one glucagonoma, four gastrinomas and in 10 tumors associated with multiple hormonal production, but not in five insulinomas or in one somatostatinoma. Grimelius reactivity was identical to chromogranin immunoreactivity in all cases except that more cells in the tumors and in the normal islets were positive for chromogranin. Both chromogranin and NSE were detected in a metastasized pancreatic endocrine tumor which had metastasized to a peripancreatic lymph node. The metastatic tumor failed to stain with antisera to all eight hormones. These results indicate that chromogranin and NSE are excellent general markers for pancreatic endocrine tumors and that the Grimelius stain and other related argyrophilic reactions may involve binding to chromogranin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205601     DOI: 10.1097/00000478-198408000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  38 in total

Review 1.  Classic and recent special stains used in differential diagnosis of endocrine tumors.

Authors:  G Bussolati; M Volante; M Papotti
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 2.  Practical markers used in the diagnosis of neuroendocrine tumors.

Authors:  Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 3.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.

Authors:  Britta Kleist; Micaela Poetsch
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

4.  Neuroendocrine differentiation in cervical carcinoma.

Authors:  P R Savargaonkar; R J Hale; A Mutton; V Manning; C H Buckley
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

Review 5.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 6.  The endocrine pancreas and its tumors.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  1993-09       Impact factor: 3.943

7.  Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors.

Authors:  R V Lloyd; M Cano; P Rosa; A Hille; W B Huttner
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

8.  Pancreatic endocrine tumour with disseminated pulmonary thromboembolism in an owl monkey (Aotus nancymae).

Authors:  A S Gozalo; P M Zerfas; M F Starost; L E Lambert; W R Elkins
Journal:  J Comp Pathol       Date:  2013-02-28       Impact factor: 1.311

9.  Immunological characterization of chromogranins A and B and secretogranin II in the bovine pancreatic islet.

Authors:  S Yoshie; C Hagn; M Ehrhart; R Fischer-Colbrie; D Grube; H Winkler; M Gratzl
Journal:  Histochemistry       Date:  1987

10.  Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.

Authors:  M Leader; M Collins; J Patel; K Henry
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.